In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19.

MLA

Mustafa, Sabeena, et al. “In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19.” Processes, vol. 10, no. 7, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/pr10071397.

APA

Mustafa, S., Alomair, L. A., & Hussein, M. (2022). In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19. Processes, 10(7), N.PAG. https://doi.org/10.3390/pr10071397

Chicago

Mustafa, Sabeena, Lamya A. Alomair, and Mohamed Hussein. 2022. “In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19.” Processes 10 (7): N.PAG. doi:10.3390/pr10071397.